Detalles de la búsqueda
1.
Evaluation of the novel therapeutic anti-CCR7 antibody CAP-100 as an add-on therapy in chronic lymphocytic leukemia patients receiving venetoclax.
Hematol Oncol
; 41(5): 869-876, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545392
2.
Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody.
Cancer Immunol Immunother
; 71(3): 627-636, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34297159
3.
Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC).
Br J Haematol
; 190(6): 854-863, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519351
4.
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.
Am J Hematol
; 95(6): 604-611, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32096887
5.
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial.
Pharm Res
; 36(7): 93, 2019 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31044267
6.
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.
Br J Haematol
; 176(4): 618-628, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27977057
7.
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
Lancet Oncol
; 17(2): 200-211, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26655421
8.
PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia.
Blood
; 124(3): 420-5, 2014 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-24916506
9.
Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.
Eur J Haematol
; 96(5): 532-40, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26179864
10.
Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia.
Cancer Immunol Immunother
; 64(6): 665-76, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25724841
11.
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.
Ann Hematol
; 94(4): 565-73, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25387664
12.
Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia.
Blood
; 120(18): 3670-6, 2012 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22915649
13.
Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study.
Cancers (Basel)
; 15(16)2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37627075
14.
Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results.
Br J Haematol
; 157(1): 67-74, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22224845
15.
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.
Br J Haematol
; 159(1): 67-77, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22861163
16.
Effect of FCGR2A and FCGR3A variants on CLL outcome.
Blood
; 116(20): 4212-22, 2010 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-20705761
17.
Ibrutinib Does Not Impact CCR7-Mediated Homeostatic Migration in T-Cells from Chronic Lymphocytic Leukemia Patients.
Cancers (Basel)
; 14(11)2022 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35681706
18.
Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL.
MAbs
; 13(1): 1917484, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944659
19.
Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study).
Clin Lymphoma Myeloma Leuk
; 21(12): e985-e999, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34511320
20.
Angioimmunoblastic T-cell lymphoma after acute myeloid leukemia: Alleged common pathogenesis. A case report and literature review.
Clin Case Rep
; 8(12): 3494-3497, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33363958